51 related articles for article (PubMed ID: 38707726)
1. Clinical, Histopathological, and Immunohistochemical Characteristics of Predictive Biomarkers of Breast Cancer: A Retrospective Study.
Papalexis P; Georgakopoulou VE; Keramydas D; Vogiatzis R; Taskou C; Anagnostopoulou FA; Nonni A; Lazaris AC; Zografos GC; Kavantzas N; Thomopoulou GE
Cancer Diagn Progn; 2024; 4(3):340-351. PubMed ID: 38707726
[TBL] [Abstract][Full Text] [Related]
2. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.
Ferguson NL; Bell J; Heidel R; Lee S; Vanmeter S; Duncan L; Munsey B; Panella T; Orucevic A
Breast J; 2013; 19(1):22-30. PubMed ID: 23240985
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Expression Of Matrix Metalloproteinase-1 (MMP-1) in Different Types Of Breast Carcinoma And Its Comparison With ER/PER and HER2/neu.
Shamsi FB; Anwar A; Lail RA; Bukhari MH; Naseem N; Nagi AH
J Ayub Med Coll Abbottabad; 2022; 34(1):12-16. PubMed ID: 35466619
[TBL] [Abstract][Full Text] [Related]
5. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
6. Multicentric mammary carcinoma: evidence of monoclonal proliferation.
Middleton LP; Vlastos G; Mirza NQ; Eva S; Sahin AA
Cancer; 2002 Apr; 94(7):1910-6. PubMed ID: 11932891
[TBL] [Abstract][Full Text] [Related]
7. What's new in breast pathology 2022: WHO 5th edition and biomarker updates.
Muller K; Jorns JM; Tozbikian G
J Pathol Transl Med; 2022 May; 56(3):170-171. PubMed ID: 35581732
[TBL] [Abstract][Full Text] [Related]
8. The role of E-Cadherin expression in primary site of breast cancer.
Karsten N; Kolben T; Mahner S; Beyer S; Meister S; Kuhn C; Schmoeckel E; Wuerstlein R; Harbeck N; Ditsch N; Jeschke U; Friese K; Kolben TM
Arch Gynecol Obstet; 2022 Apr; 305(4):913-920. PubMed ID: 34510244
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer.
Davey MG; Hynes SO; Kerin MJ; Miller N; Lowery AJ
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503265
[TBL] [Abstract][Full Text] [Related]
10. Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma.
Aznab M; Khajevand Ahmady M; Jamshidi K; Madani SH; Khazaei S; Shoushtaryzadeh T; Bagheri A
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3005-3009. PubMed ID: 33112560
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
Allison KH; Hammond MEH; Dowsett M; McKernin SE; Carey LA; Fitzgibbons PL; Hayes DF; Lakhani SR; Chavez-MacGregor M; Perlmutter J; Perou CM; Regan MM; Rimm DL; Symmans WF; Torlakovic EE; Varella L; Viale G; Weisberg TF; McShane LM; Wolff AC
J Clin Oncol; 2020 Apr; 38(12):1346-1366. PubMed ID: 31928404
[TBL] [Abstract][Full Text] [Related]
12. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Burstein HJ; Curigliano G; Loibl S; Dubsky P; Gnant M; Poortmans P; Colleoni M; Denkert C; Piccart-Gebhart M; Regan M; Senn HJ; Winer EP; Thurlimann B;
Ann Oncol; 2019 Oct; 30(10):1541-1557. PubMed ID: 31373601
[TBL] [Abstract][Full Text] [Related]
13. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Cardoso F; Kyriakides S; Ohno S; Penault-Llorca F; Poortmans P; Rubio IT; Zackrisson S; Senkus E;
Ann Oncol; 2019 Aug; 30(8):1194-1220. PubMed ID: 31161190
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
